|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.21 USD | -5.99% |
|
-3.70% | +0.28% |
| 07-17 | Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares | MT |
| 07-04 | Certain Common Stock of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVALO THERAPEUTICS, INC. | Bio Therapeutic Drugs | -5.99% | -3.70% | +0.28% | +191.36% | -99.78% | 1.02B |  |  | |
- Stock Market
- Stocks
- AVTX Stock
- Charts Avalo Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
